JP2023520929A5 - - Google Patents
Info
- Publication number
- JP2023520929A5 JP2023520929A5 JP2022561484A JP2022561484A JP2023520929A5 JP 2023520929 A5 JP2023520929 A5 JP 2023520929A5 JP 2022561484 A JP2022561484 A JP 2022561484A JP 2022561484 A JP2022561484 A JP 2022561484A JP 2023520929 A5 JP2023520929 A5 JP 2023520929A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- optionally
- cov
- sars
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026018466A JP2026077677A (ja) | 2020-04-10 | 2026-02-06 | コロナウイルス感染症の処置のための方法 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063008624P | 2020-04-10 | 2020-04-10 | |
| US63/008,624 | 2020-04-10 | ||
| US202063023021P | 2020-05-11 | 2020-05-11 | |
| US63/023,021 | 2020-05-11 | ||
| US16/875,487 | 2020-05-15 | ||
| US16/875,487 US11116737B1 (en) | 2020-04-10 | 2020-05-15 | Methods of using probenecid for treatment of coronavirus infections |
| EP20202059.0A EP3892269B1 (en) | 2020-04-10 | 2020-10-15 | Probenecid for treating coronavirus infections |
| EP20202059.0 | 2020-10-15 | ||
| US202163151551P | 2021-02-19 | 2021-02-19 | |
| US63/151,551 | 2021-02-19 | ||
| PCT/US2021/026588 WO2021207606A1 (en) | 2020-04-10 | 2021-04-09 | Methods for treatment of coronavirus infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018466A Division JP2026077677A (ja) | 2020-04-10 | 2026-02-06 | コロナウイルス感染症の処置のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520929A JP2023520929A (ja) | 2023-05-22 |
| JP2023520929A5 true JP2023520929A5 (cg-RX-API-DMAC7.html) | 2024-04-16 |
| JP7840570B2 JP7840570B2 (ja) | 2026-04-06 |
Family
ID=78023981
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561484A Active JP7840570B2 (ja) | 2020-04-10 | 2021-04-09 | コロナウイルス感染症の処置のための方法 |
| JP2026018466A Pending JP2026077677A (ja) | 2020-04-10 | 2026-02-06 | コロナウイルス感染症の処置のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018466A Pending JP2026077677A (ja) | 2020-04-10 | 2026-02-06 | コロナウイルス感染症の処置のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4132503B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7840570B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116075298B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021254262A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3074777T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021207606A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230302031A1 (en) * | 2020-06-02 | 2023-09-28 | Institut Gustave-Roussy | Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome |
| AU2022309236A1 (en) * | 2021-07-06 | 2024-01-25 | University Of Georgia Research Foundation, Inc. | Compositions and methods for treating and preventing viral infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1649053A4 (en) * | 2003-06-18 | 2006-10-18 | Chinese Nat Human Genome Ct Sh | CHARACTERIZATION OF THE EARLY LEVELS OF THE VIRUS OF HEAVY ACUTE RESPIRATORY SYNDROME (SARS) AND USES THEREOF |
| WO2011127019A2 (en) * | 2010-04-07 | 2011-10-13 | Celgene Corporation | Methods for treating respiratory viral infection |
| WO2011146527A2 (en) | 2010-05-17 | 2011-11-24 | Zirus, Inc. | Mammalian genes involved in infection |
| US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| HUE062848T2 (hu) * | 2018-09-14 | 2023-12-28 | Enlitisa Shanghai Pharmaceutical Co Ltd | Montelukaszt és peptidek konjugátumai |
| AU2020289560A1 (en) * | 2019-06-05 | 2021-12-23 | Emory University | Peptidomimetics for the treatment of coronavirus and picornavirus infections |
-
2021
- 2021-04-09 WO PCT/US2021/026588 patent/WO2021207606A1/en not_active Ceased
- 2021-04-09 EP EP21785329.0A patent/EP4132503B1/en active Active
- 2021-04-09 AU AU2021254262A patent/AU2021254262A1/en active Pending
- 2021-04-09 ES ES21785329T patent/ES3074777T3/es active Active
- 2021-04-09 JP JP2022561484A patent/JP7840570B2/ja active Active
- 2021-04-09 CN CN202180037562.1A patent/CN116075298B/zh active Active
-
2026
- 2026-02-06 JP JP2026018466A patent/JP2026077677A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522010A5 (cg-RX-API-DMAC7.html) | ||
| JP2023535744A5 (cg-RX-API-DMAC7.html) | ||
| US20230201497A1 (en) | Method for pulsatile delivery of a gaseous drug | |
| JP2023520323A5 (cg-RX-API-DMAC7.html) | ||
| EA022840B1 (ru) | Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа | |
| US20220387455A1 (en) | Treatment of moderate to severe influenza | |
| CN111658779A (zh) | 治疗新型冠状病毒肺炎的联合用药物 | |
| JP2024504225A5 (cg-RX-API-DMAC7.html) | ||
| JP2023520591A5 (cg-RX-API-DMAC7.html) | ||
| JP2022553888A5 (cg-RX-API-DMAC7.html) | ||
| JP2024531799A5 (cg-RX-API-DMAC7.html) | ||
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物 | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| WO2022199049A1 (zh) | 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途 | |
| JP2023539847A5 (cg-RX-API-DMAC7.html) | ||
| JP2024543259A5 (cg-RX-API-DMAC7.html) | ||
| CN115884770A (zh) | 治疗冠状病毒感染的联用药物及治疗方法 | |
| CN115867288A (zh) | 用于治疗呼吸系统病症的组合物 | |
| Van Wyk | The common cold and influenza: colds & flu | |
| US12171732B2 (en) | Compositions and use of N-chlorotaurine for treatment and prevention of respiratory infections | |
| JP2024537906A5 (cg-RX-API-DMAC7.html) | ||
| KR20250053864A (ko) | 호흡기 감염을 치료하기 위한 약제학적 건조 분말 조성물 및 방법 | |
| CN116531491A (zh) | 一种干扰素α1b在制备防治甲型流感病毒感染引发的疾病的药物中的用途 | |
| BR102020005172A2 (pt) | Zinco como medicamento antiviral eficaz para a família coronaviridae e seus genomas, gêneros e grupos | |
| HK40096303A (en) | Bupropion and dextromethorphan for reduction of suicide risk in depression patients |